title: Complement: help or hindrance?
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Beers
authors.forename: Mark S
authors.initials: MS
authors.lastname: Cragg
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Glennie
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003176:Complement C3 / Q000172:deficiency*; D004195:Disease Models, Animal; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D051379:Mice
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D003176:Complement C3